KOR

e-Article

Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial
Document Type
Article
Author
Lyttle, Mark DRainford, Naomi E AGamble, CarrolMessahel, ShroukHumphreys, AmyHickey, HelenWoolfall, KerryRoper, LouiseNoblet, JoanneLee, Elizabeth DPotter, SarahTate, PaulIyer, AnandEvans, VickiAppleton, Richard EPereira, MatthewHardwick, SusieMessahel, ShroukNoblet, JoanneLee, Elizabeth DGreenwood-Bibby, RachelBuchanan, MarkLewis, LucyHughes, SharonHartshorn, StuartRogers, LouiseHopkins, JulietLyttle, Mark DFernandez, DaphinPotter, SarahLavigne-Smith, Holly RMoulsdale, PhoebeSmith, AliceBingham, TraceyRoss, JamesRamsey, NatashaHacking, JoMullen, NiallCorrigan, Paul PPrudhoe, SarahFaza, HaniRobinson, GiselaSunley, Rachel CSmith, Coral JUnsworth, VanessaCriddle, JohnLaque, MartinSheedy, Alyce BAnderson, MarkBell, KathrynDevine, KirstyScott, AlexKumar, RameshArmstrong, SoniaSutherland, EmerCantle, FleurHelyer, SineadRiozzi, PaulCotton, HannahDownes, Alice JMollard, HelenRoland, DamianHay, FelixGough, ChristopherFinucane, SonyaBevan, CatherineRamsay, RebeccaWalton, EmilyManey, Julie-AnnDalzell, ElizabethMillar, MurielHowells, Rachel JAppelboam, AndyMackle, DaisySmall, JennieNeil, AshleighChoudhery, VinceMacLeod, StewartBrowning, JenO'Neill, ThomasGrahamslaw, JuliaParikh, AmiSkene, ImogenThomas, RhysPotier de la Morandiere, KatherineWilson, Jill LDanziger, DonnaBurke, DerekRamlakhan, ShammiEvans, JayneMorcombe, JulieGormley, StuartBarling, Jason MCathie, KatrinaBayreuther, JaneEnsom, RuthIqbal, YasserRounding, SarahMulligan, JoanneBell, ClaireMcLellan, ShonaLeighton, ShonaSajjanhar, TinaNyirenda, MaggieCrome, LauraWilliamson, NeilAlcock, AnastasiaEdwards, SaraMorgan, JeffPowell, Colin VERamesh, Chaniyil AKamal-Uddin, SolomonLinney, MikeVamvakiti, KatiaFloyd, SharonHobden, Gill
Source
The Lancet; May 2019, Vol. 393 Issue: 10186 p2125-2134, 10p
Subject
Language
ISSN
01406736; 1474547X
Abstract
Phenytoin is the recommended second-line intravenous anticonvulsant for treatment of paediatric convulsive status epilepticus in the UK; however, some evidence suggests that levetiracetam could be an effective and safer alternative. This trial compared the efficacy and safety of phenytoin and levetiracetam for second-line management of paediatric convulsive status epilepticus.